NCT03432195View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions
Alzheimer's Disease
Interventions
DRUG

Donepezil TDS

Donepezil Hydrochloride Transdermal Delivery System

Trial Locations (1)

85283

Celerion, Tempe

All Listed Sponsors
lead

Corium, Inc.

INDUSTRY

NCT03432195 - A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations | Biotech Hunter | Biotech Hunter